Wencui Chen
305 East Zhongshan Road
Nanjing, 210016, China
Nanjing, 210016, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Comparison of bortezomib with dexamethasone and thalidomide with dexamethasone in the treatment of patients with monoclonal immunoglobulin deposition disease.
Journal: Journal of nephrology
Published: January 25, 2026
B -Cell Maturation Antigen-CD19 Dual-Targeted Chimeric Antigen Receptor- T -Cell Therapy for Relapsed or Refractory AL Amyloidosis.
Journal: Journal of the American Society of Nephrology : JASN
Published: December 26, 2025
Long-term outcomes of autologous stem cell transplantation for AL amyloidosis: a 15-year experience from a Chinese referral center and a comparison of different eras.
Journal: Blood cancer journal
Published: November 10, 2025
Long-Term Outcomes in Patients with Renal Systemic Light Chain Amyloidosis.
Journal: Kidney diseases (Basel, Switzerland)
Published: October 06, 2025
Bortezomib combined with autologous stem cell transplantation overcomes cytogenetic abnormalities in AL amyloidosis.
Journal: International journal of hematology
Published: August 13, 2025
The pre-ASCT serum albumin and pre-ASCT dFLC are prognostic markers in renal light chain amyloidosis patients treated with autologous stem cell transplantation.
Journal: Bone marrow transplantation
Published: December 31, 2024
Serum free light chain level-based and non-fixed cycle daratumumab treatment strategy for patients with light chain amyloidosis.
Journal: Annals of medicine
Published: December 19, 2024
Dapagliflozin in maturity-onset diabetes of the young with HNF1A mutation and diabetic nephropathy.
Journal: International urology and nephrology
Published: November 01, 2024
Autologous hematopoietic stem cell transplantation for non-AL amyloidosis monoclonal gammopathy of renal significance.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: October 31, 2024
Clinical Manifestations and Prognosis of Chronic Kidney Disease after Hematopoietic Stem Cell Transplantation.
Journal: Kidney diseases (Basel, Switzerland)
Published: October 11, 2024
Efficiency and safety of granulocyte colony-stimulating factor combined with plerixafor for autologous peripheral blood hematopoietic stem cell mobilization in light chain amyloidosis.
Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
Published: August 20, 2024
Risk factors, treatments and outcomes of patients with light chain amyloidosis who relapse after autologous stem cell transplantation.
Journal: Bone marrow transplantation
Published: October 16, 2023
Last Updated: 09/26/2026